25 July, 2014 09:09 IST
News
Aurobindo gains on USFDA approval for Oxacillin
Source: IRIS (21-JAN-13)
Comments  |  Post Comment

Aurobindo Pharma, a mid-size pharmaceutical company, gained on Monday after it has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Oxacillin for Injection USP, packaged in 1g and 2g vials and Oxacillin for Injection USP 10g/Vial pharmacy bulk package.

Oxacillin for Injection USP is a sterile semisynthetic penicillin (SSP) indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug.

Shares of the company are trading at Rs 195.70, up Rs 3.1, or 1.61% at the Bombay Stock Exchange (BSE) on Monday at 11:42 a.m.

The scrip has touched an intra-day high of Rs 196.70 and low of Rs 193.10. The total volume of shares traded at the BSE is 105,697.

In the earlier session, the shares gained 2.15%, or Rs 4.05, at Rs 192.60. Currently, the stock is trading down 4.49% from its 52-week high of Rs 204.90 and above 104.81% over the 52-week low of Rs 95.55.



Share Price Movement
Period Price
in Rs
Gain/(Loss)
in Rs in %
1 Week 184.55 8.05 4.36
1 Month 195.10 (2.50) (1.28)
3 Months 156.80 35.80 22.83
6 Months 108.40 84.20 77.68
1 Year 100.10 92.50 92.41
Note: Based on previous day closing price.


Aurobindo Pharma Limited   (Q,N,C,F)*


Sector News
Wipro standalone quarterly profit jumps 54.50% - 24-Jul-2014 18:17
Zensar Technologies consolidated quarterly profit drops 8.17% - 24-Jul-2014 16:56
Experts welcome hike in FDI for insurance industry - 24-Jul-2014 16:55
India's mobile services market to reach USD 19.2 bn in 2014: Gartner - 24-Jul-2014 16:45
FDI cap of 49% in insurance industry is a welcome move: Rajesh Sud - 24-Jul-2014 16:40
ASEAN banks face high household leverage as credit cycle peaks: Moody's - 24-Jul-2014 16:21
Mastek consolidated quarterly earnings plunges 88.01% - 24-Jul-2014 13:51
FDI cap in insurance sector will ensure development of country at large: Kshitij Jain - 24-Jul-2014 13:41
BHEL executes R&M of 110 MW Unit-4 of Punjab thermal plant - 24-Jul-2014 12:56
Cairn India consolidated quarterly profit plunges 65% - 24-Jul-2014 12:01
TAQA withdraws acquisition transaction from JP Power - 24-Jul-2014 11:58
more...
* Q - Quote , N - News , C - Chart , F - Financials
Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type   2z9dfp into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Forums  |   E-mail  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer